Differential induction of CYP1A1 and CYP1B1 by benzo[a]pyrene in oral squamous cell carcinoma cell lines and by tobacco smoking in oral mucosa

Oral Oncology

Volumn 45, Issue 11, 2009, Pages 980-985

  Chi, Angela C ^a   Appleton, Kathryn ^a   Henriod, Joel B ^a   Krayer, Joe W ^a   Marlow, Nicole M ^b   Bandyopadhyay, Dipankar ^b   Sigmon, Ryan C ^a   Kurtz, David T ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Experimental Therapeutics   (United States)

Author keywords

CYP1A1; CYP1B1; Oral cancer; Squamous cell carcinoma; Tobacco

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1;

ADULT; ARTICLE; CANCER RISK; CARCINOMA CELL; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GINGIVA; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; SMOKING;

EID: 70349904300     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.05.562     Document Type: Article

References (37)

1. Reibel J. Tobacco and oral diseases. Update on the evidence, with recommendations. Med Princ Pract 12 Suppl 1 (2003) 22-32
2. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3 (2003) 733-744
3. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91 (1999) 1194-1210
4. Baird W.M., Hooven L.A., and Mahadevan B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45 (2005) 106-114
5. Umannova L., Machala M., Topinka J., Novakova Z., Milcova A., Kozubik A., et al. Tumor necrosis factor-alpha potentiates genotoxic effects of benzo[a]pyrene in rat liver epithelial cells through upregulation of cytochrome P450 1B1 expression. Mutat Res 640 (2008) 162-169
6. Xue W., and Warshawsky D. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206 (2005) 73-93
7. Thier R., Bruning T., Roos P.H., and Bolt H.M. Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer. Arch Toxicol 76 (2002) 249-256
8. Walle T., Walle U.K., Sedmera D., and Klausner M. Benzo[a]pyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue. Drug Metab Dispos 34 (2006) 346-350
9. Wen X., and Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26 (2005) 1774-1781
10. Singh A.P., Shah P.P., Mathur N., Buters J.T., Pant M.C., and Parmar D. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res 639 (2008) 11-19
11. Ko Y., Abel J., Harth V., Brode P., Antony C., Donat S., et al. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 61 (2001) 4398-4404
12. Nagaraj N.S., Beckers S., Mensah J.K., Waigel S., Vigneswaran N., and Zacharias W. Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicol Lett 165 (2006) 182-194
13. Spivack S.D., Hurteau G.J., Jain R., Kumar S.V., Aldous K.M., Gierthy J.F., et al. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res 64 (2004) 6805-6813
14. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
15. Hollander M., and Wolfe D.A. Section 4.1 A distribution-free rank sum test (Wilcoxon, Mann and Whitney). Nonparametric statistical methods. 2nd ed. (1999), Wiley, New York p. 106-24
16. Hollander M., and Wolfe D.A. Section 6.1 A distribution-free test for general alternatives (Kruskal-Wallis). Nonparametric statistical methods. 2nd ed. (1999), Wiley, New York p. 190-9
17. Piscaglia F., Knittel T., Kobold D., Barnikol-Watanabe S., Di Rocco P., and Ramadori G. Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. Biochem Pharmacol 58 (1999) 157-165
18. Ke S., Rabson A.B., Germino J.F., Gallo M.A., and Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J Biol Chem 276 (2001) 39638-39644
19. Abdel-Razzak Z., Corcos L., Fautrel A., Campion J.P., and Guillouzo A. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol 46 (1994) 1100-1110
20. Uno S., Dalton T.P., Shertzer H.G., Genter M.B., Warshawsky D., Talaska G., et al. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels. Biochem Biophys Res Commun 289 (2001) 1049-1056
21. Page T.J., O'Brien S., Holston K., MacWilliams P.S., Jefcoate C.R., and Czuprynski C.J. 7,12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent. Toxicol Sci 74 (2003) 85-92
22. Buters J.T., Mahadevan B., Quintanilla-Martinez L., Gonzalez F.J., Greim H., Baird W.M., et al. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. Chem Res Toxicol 15 (2002) 1127-1135
23. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., et al. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96 (1999) 1977-1982
24. Uno S., Dalton T.P., Dragin N., Curran C.P., Derkenne S., Miller M.L., et al. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxification, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharmacol 69 (2006) 1103-1114
25. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279 (2004) 23847-23850
26. Murray G.I., Taylor M.C., McFadyen M.C., McKay J.A., Greenlee W.F., Burke M.D., et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57 (1997) 3026-3031
27. Murray G.I., Melvin W.T., Greenlee W.F., and Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 41 (2001) 297-316
28. Rieder C.R., Ramsden D.B., and Williams A.C. Cytochrome P450 1B1 mRNA in the human central nervous system. Mol Pathol 51 (1998) 138-142
29. Sutter T.R., Tang Y.M., Hayes C.L., Wo Y.Y., Jabs E.W., Li X., et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269 (1994) 13092-13099
30. Willey J.C., Coy E.L., Frampton M.W., Torres A., Apostolakos M.J., Hoehn G., et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 17 (1997) 114-124
31. Gattás G.J., de Carvalho M.B., Siraque M.S., Curioni O.A., Kohler P., Eluf-Neto J., et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28 (2006) 819-826
32. Varela-Lema L., Taioli E., Ruano-Ravina A., Barros-Dios J.M., Anantharaman D., Benhamou S., et al. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 10 (2008) 369-384
33. Fontana R.J., Lown K.S., Paine M.F., Fortlage L., Santella R.M., Felton J.S., et al. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117 (1999) 89-98
34. Goldman R., and Shields P.G. Food mutagens. J Nutr 133 Suppl 3 (2003) 965S-973S
35. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutat Res 443 (1999) 139-147
36. Ward M.H., Sinha R., Heineman E.F., Rothman N., Markin R., Weisenburger D.D., et al. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 71 (1997) 14-19
37. Kazerouni N., Sinha R., Hsu C.H., Greenberg A., and Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 39 (2001) 423-436